Effect of increase in duration of aprepitant consumption from 3 to 6 days on the prevention of nausea and vomiting in women receiving combination of anthracycline/cyclophosphamide chemotherapy: A randomized, crossover, clinical trial

BACKGROUND: Aprepitant is one of the effective antiemetic drugs that usually used for a period of 3 days for prevention of anthracycline/cyclophosphamide (AC) induced nausea and vomiting. However, many patients still experience nausea and vomiting on days 3–5. The aim of this study was to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahvazi, Negah Chaabi, Hemati, Simin, Mohamadianpanah, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673705/
https://www.ncbi.nlm.nih.gov/pubmed/26682204
http://dx.doi.org/10.4103/2277-9175.168605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673705/
https://www.ncbi.nlm.nih.gov/pubmed/26682204
http://dx.doi.org/10.4103/2277-9175.168605

Ejemplares similares